January 2nd, 2013 - Volume 27 - Issue 1
pp: F1-F5,1-150




Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patients

Larrouy, Lucile; Vivot, Alexandre; Charpentier, Charlotte; More

AIDS. 27(1):69-80, January 2nd, 2013.

Concise Communications


Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

Anta, Lourdes; Llibre, Josep M.; Poveda, Eva; More

AIDS. 27(1):81-85, January 2nd, 2013.

Long-term immunogenicity of two doses of 2009 A/H1N1v vaccine with and without AS03A adjuvant in HIV-1-infected adults

Durier, Christine; Desaint, Corinne; Lucht, Frédéric; More

AIDS. 27(1):87-93, January 2nd, 2013.


Predictors of pregnancy and changes in pregnancy incidence among HIV-positive women accessing HIV clinical care

Huntington, Susie E.; Thorne, Claire; Bansi, Loveleen K.; More

AIDS. 27(1):95-103, January 2nd, 2013.

Population dynamics of HIV-2 in rural West Africa: comparison with HIV-1 and ongoing transmission at the heart of the epidemic

de Silva, Thushan I.; van Tienen, Carla; Onyango, Clayton; More

AIDS. 27(1):125-134, January 2nd, 2013.



Is etravirine and two nucleosides an option for HIV with an isolated K103N mutation?

Estebanez, Miriam; Stella-Ascariz, Natalia; Ruiz-Carrascoso, Guillermo; More

AIDS. 27(1):141-144, January 2nd, 2013.


1 2 3 4 5